Lazard Asset Management LLC Astrazeneca PLC Transaction History
Lazard Asset Management LLC
- $70 Billion
- Q3 2025
A detailed history of Lazard Asset Management LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Lazard Asset Management LLC holds 1,334,560 shares of AZN stock, worth $119 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
1,334,560
Previous 1,126,910
18.43%
Holding current value
$119 Million
Previous $78.7 Million
30.02%
% of portfolio
0.15%
Previous 0.12%
Shares
19 transactions
Others Institutions Holding AZN
# of Institutions
1,498Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...